GLOBUS MEDICAL INC (GMED) is a publicly traded Healthcare sector company. As of July 5, 2026, GMED trades at $80.12 with a market cap of $10.88B and a P/E ratio of 105.42. GMED moved +5.48% today. Year to date, GMED is -8.86%; over the trailing twelve months it is +32.28%. Its 52-week range spans $51.79 to $101.40. Analyst consensus is strong buy with an average price target of $111.00. Rallies surfaces GMED's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks GMED insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $80.12 |
| Market Cap | $10.88B |
| P/E Ratio | 105.42 |
| EPS | $0.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $101.40 |
| 52-Week Low | $51.79 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.52B |
| Net Income | $102.98M |
| Gross Margin | 58.90% |
10 analysts cover GMED: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $111.00.